Yunling Xu

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 8

Top Topics

Machine Learning

Artificial Intelligence

Top Venues

Pharmaceutical statistics

Therapeutic innovation & regulatory science

This page only lists publications with an associated author ORCID identifier.

Publications

Wei-Chen Chen, Nelson Lu, Chenguang Wang, Heng Li, Changhong Song, Ram Tiwari, Yunling Xu, Lilly Q Yue
A propensity score-integrated approach for leveraging external data in a randomized controlled trial with time-to-event endpoints. Pharmaceutical statistics (2024)
Nelson Lu, Wei-Chen Chen, Heng Li, Changhong Song, Ram Tiwari, Chenguang Wang, Yunling Xu, Lilly Q Yue
Propensity score-incorporated adaptive design approaches when incorporating real-world data. Pharmaceutical statistics (2023)
Changhong Song, Heng Li, Wei-Chen Chen, Nelson Lu, Ram Tiwari, Chenguang Wang, Yunling Xu, Lilly Q Yue
Principled leveraging of external data in the evaluation of diagnostic devices via the propensity score-integrated composite likelihood approach. Pharmaceutical statistics (2023)
Xuan Ye, Nelson Lu, Yunling Xu
Improving precision and power in randomized trials with a two-stage study design: Stratification using clustering method. Pharmaceutical statistics 22 (2) (2022)
Xuan Ye, Nelson Lu, Yunling Xu
Improving precision and power in randomized trials with a two-stage study design: Stratification using clustering method. Pharmaceutical statistics (2022)
Xuan Ye, Nelson Lu, Yunling Xu
Improving precision and power in randomized trials with a two-stage study design: Stratification using clustering method. Pharmaceutical statistics 22 (2) (2022)
Xuan Ye, Nelson Lu, Yunling Xu
Improving precision and power in randomized trials with a two-stage study design: Stratification using clustering method. Pharmaceutical statistics 22 (2) (2022)
Yunling Xu, Nelson Lu, Lilly Yue, Ram Tiwari
A Study Design for Augmenting the Control Group in a Randomized Controlled Trial: A Quality Process for Interaction Among Stakeholders. Therapeutic innovation & regulatory science 54 (2) (2020)